We hope inotersen will be available to patients in the UK very soon,” he added. After a confidential price cut, Akcea has persuaded NICE to change its position on Tegsedi, paving the way for the ...

The FDA has approved Ionis Pharmaceuticals’ RNA silencing drug Tegsedi (inotersen) for nerve damage caused by a rare disease. This is the second drug to hit the market this year for ...